|
|
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
Randomized, double-blind study comparing the immunogenicity of two different brands of human Insulin for the treatment of diabetes. - Nil
/ Not yet recruitingNot Applicable Randomized, double-blind study comparing the immunogenicity of two different brands of human insulin for the treatment of diabetes
100 Clinical Results associated with Marvel Life Sciences Pvt Ltd.
0 Patents (Medical) associated with Marvel Life Sciences Pvt Ltd.
100 Deals associated with Marvel Life Sciences Pvt Ltd.
100 Translational Medicine associated with Marvel Life Sciences Pvt Ltd.